Prognosis
Germany Looks Beyond EU Deal to Secure Covid Vaccine Doses
This article is for subscribers only.
Germany is conducting direct negotiations with domestic Covid-19 vaccine developers to obtain more doses than would be allocated through the shared European Union plan, Health Minister Jens Spahn said.
The country is in talks with BioNTech SE, Pfizer Inc.’s partner on the first vaccine approved in a Western country against the virus, as well as CureVac NV and IDT Biologika GmbH, Spahn said Wednesday. All three German companies received funding through a government program to support Covid vaccine development.